MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells

Journal of Ovarian Research

Volumn 4, Issue 1, 2011, Pages

  Ponnusamy, Moorthy P ^a   Seshacharyulu, Parthasarathy ^a   Vaz, Arokiapriyanka ^a   Dey, Parama ^a   Batra, Surinder K ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cancer Stem Cells; CD133; HER2; MUC4; Ovarian Cancer; Side Population

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD133 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MUCIN 4; SONIC HEDGEHOG PROTEIN;

ARTICLE; CANCER CELL; CANCER STEM CELL; CELL POPULATION; COLONY FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIDE POPULATION CELL; WESTERN BLOTTING;

EID: 79955105128     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-4-7     Document Type: Article

References (28)

1. Ovarian cancer: emerging concept on cancer stem cells. MP Ponnusamy SK Batra, J Ovarian Res 2008 1 4 10.1186/1757-2215-1-4 19014671
2. Tumour stem cells and drug resistance. M Dean T Fojo S Bates, Nat Rev Cancer 2005 5 275 284 10.1038/nrc1590 15803154 (Pubitemid 40488633)
3. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. M Andrianifahanana N Moniaux BM Schmied J Ringel H Friess MA Hollingsworth MW Buchler JP Aubert SK Batra, Clin Cancer Res 2001 7 4033 4040 11751498 (Pubitemid 34044624)
4. Mucins in cancer: protection and control of the cell surface. MA Hollingsworth BJ Swanson, Nat Rev Cancer 2004 4 45 60 10.1038/nrc1251 14681689 (Pubitemid 38082153)
5. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). SC Chauhan AP Singh F Ruiz SL Johansson M Jain LM Smith N Moniaux SK Batra, Mod Pathol 2006 19 1386 1394 10.1038/modpathol.3800646 16880776 (Pubitemid 44423087)
6. Mucin gene expression in ovarian cancers. RL Giuntoli GC Rodriguez RS Whitaker R Dodge JA Voynow, Cancer Res 1998 58 5546 5550 9850092 (Pubitemid 28551143)
7. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. P Chaturvedi AP Singh S Chakraborty SC Chauhan S Bafna JL Meza PK Singh MA Hollingsworth PP Mehta SK Batra, Cancer Res 2008 68 2065 2070 10.1158/0008-5472.CAN-07-6041 18381409 (Pubitemid 351521776)
8. MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells. MP Ponnusamy AP Singh M Jain S Chakraborty N Moniaux SK Batra, Br J Cancer 2008 99 520 526 10.1038/sj.bjc.6604517 18665193
9. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells. MP Ponnusamy I Lakshmanan M Jain S Das S Chakraborty P Dey SK Batra, Oncogene 2010 29 5741 5754 10.1038/onc.2010.309 20697346
10. HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. H Korkaya A Paulson F Iovino MS Wicha, Oncogene 2008 27 6120 6130 10.1038/onc.2008.207 18591932
11. MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. K Engelmann H Shen OJ Finn, Cancer Res 2008 68 2419 2426 10.1158/0008-5472.CAN-07-2249 18381450 (Pubitemid 351521817)
12. Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells. N Moniaux P Chaturvedi GC Varshney JL Meza JF Rodriguez-Sierra JP Aubert SK Batra, Br J Cancer 2007 97 345 357 10.1038/sj.bjc.6603868 17595659 (Pubitemid 47196741)
13. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. PP Szotek R Pieretti-Vanmarcke PT Masiakos DM Dinulescu D Connolly R Foster D Dombkowski F Preffer DT Maclaughlin PK Donahoe, Proc Natl Acad Sci USA 2006 103 11154 11159 10.1073/pnas.0603672103 16849428 (Pubitemid 44156488)
14. ABC transporters as phenotypic markers and functional regulators of stem cells. KD Bunting, Stem Cells 2002 20 11 20 10.1002/stem.200011 11796918 (Pubitemid 34118906)
15. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. M Kim H Turnquist J Jackson M Sgagias Y Yan M Gong M Dean JG Sharp K Cowan, Clin Cancer Res 2002 8 22 28 11801536 (Pubitemid 34101455)
16. Expression of CD133-1 and CD133-2 in ovarian cancer. G Ferrandina G Bonanno L Pierelli A Perillo A Procoli A Mariotti M Corallo E Martinelli S Rutella A Paglia G Zannoni S Mancuso G Scambia, Int J Gynecol Cancer 2008 18 506 514 10.1111/j.1525-1438.2007.01056.x 17868344 (Pubitemid 351668323)
17. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. S Ma TK Lee BJ Zheng KW Chan XY Guan, Oncogene 2008 27 1749 1758 10.1038/sj.onc.1210811 17891174 (Pubitemid 351380265)
18. The biology of ovarian cancer. N Auersperg MI Edelson SC Mok SW Johnson TC Hamilton, Semin Oncol 1998 25 281 304 9633841 (Pubitemid 28272603)
19. Cancer statistics, 2009. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun, CA Cancer J Clin 2009 59 225 249 10.3322/caac.20006 19474385
20. Ovarian surface epithelium: family history and early events in ovarian cancer. AS Wong N Auersperg, Reprod Biol Endocrinol 2003 1 70 10.1186/1477-7827-1-70 14609432
21. Prospective identification of tumorigenic breast cancer cells. M Al-Hajj MS Wicha A ito-Hernandez SJ Morrison MF Clarke, Proc Natl Acad Sci USA 2003 100 3983 3988 10.1073/pnas.0530291100 12629218 (Pubitemid 36418143)
22. Prospective identification of tumorigenic prostate cancer stem cells. AT Collins PA Berry C Hyde MJ Stower NJ Maitland, Cancer Res 2005 65 10946 10951 10.1158/0008-5472.CAN-05-2018 16322242 (Pubitemid 41713363)
23. Phenotypic characterization of human colorectal cancer stem cells. P Dalerba SJ Dylla IK Park R Liu X Wang RW Cho T Hoey A Gurney EH Huang DM Simeone AA Shelton G Parmiani C Castelli MF Clarke, Proc Natl Acad Sci USA 2007 104 10158 10163 10.1073/pnas.0703478104 17548814 (Pubitemid 47175279)
24. Breast tumor-initiating cells isolated from patient core biopsies for study of hormone action. CG Marsden MJ Wright R Pochampally BG Rowan, Methods Mol Biol 2009 590 363 375 10.1007/978-1-60327-378-7-23 19763516
25. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. M Mimeault R Hauke PP Mehta SK Batra, J Cell Mol Med 2007 11 981 1011 10.1111/j.1582-4934.2007.00088.x 17979879 (Pubitemid 350037046)
26. Mucin gene transcripts in benign and borderline mucinous tumours of the ovary: an in situ hybridization study. F Boman MP Buisine A Wacrenier D Querleu JP Aubert N Porchet, J Pathol 2001 193 339 344 10.1002/1096-9896(2000)9999: 9999<::AID-PATH7983.0.CO;2-9 11241413 (Pubitemid 32229865)
27. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. AP Singh N Moniaux SC Chauhan JL Meza SK Batra, Cancer Res 2004 64 622 630 10.1158/0008-5472.CAN-03-2636 14744777 (Pubitemid 38120902)
28. Muc4-ErbB2 complex formation and signaling in polarized CACO-2 epithelial cells indicate that Muc4 acts as an unorthodox ligand for ErbB2. VP Ramsauer V Pino A Farooq CA Carothers Carraway PJ Salas KL Carraway, Mol Biol Cell 2006 17 2931 2941 10.1091/mbc.E05-09-0895 16624867 (Pubitemid 43993498)